NCT02297100 - Intravesicular Onabotulinumtoxin A in Interstitial Cystitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

January 10, 2018

Study Completion Date

January 10, 2018

Conditions

Interstitial Cystitis

Interventions

DRUG

Onabotulinumtoxin A

100 units of botox spread out among 10 separate injections

PROCEDURE

injections upper aspect of trigone of urinary bladder

We hypothesize that injections into the trigone should be more effective in the treatment of IC than injections elsewhere in the bladder.

PROCEDURE

injections on posterior bladder wall excluding the trigone

We hypothesize that injections into the trigone should be more effective in the treatment of IC than injections elsewhere in the bladder.

Trial Locations (1)

Wake Forest School of Medicine, Winston-Salem